|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.997
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.995
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.993
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.991
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.989
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.989
|
Human Mouse |
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.985
|
|
|
|
cartilage condensation
|
GO:0001502 |
18 |
0.984
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.984
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.983
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.982
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.980
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.975
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.974
|
Mouse |
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.964
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.963
|
Mouse |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.953
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.950
|
|
|
|
cell aggregation
|
GO:0098743 |
18 |
0.944
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.944
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.943
|
Mouse |
|
|
blood circulation
|
GO:0008015 |
195 |
0.940
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.939
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.935
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.933
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.933
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.923
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.920
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.915
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.907
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.901
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.892
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.886
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.882
|
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.882
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.871
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.871
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.837
|
|
|
|
negative regulation of blood circulation
|
GO:1903523 |
15 |
0.837
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.833
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.828
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.828
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.826
|
|
|
|
positive regulation of interferon gamma secretion
|
GO:1902715 |
3 |
0.822
|
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.816
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.815
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.801
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.798
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.796
|
|
|
|
aorta smooth muscle tissue morphogenesis
|
GO:0060414 |
2 |
0.786
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.776
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.770
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.767
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.763
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.756
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.752
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.752
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.752
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.749
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.741
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.731
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.730
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.723
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.722
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.720
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.719
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.708
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.704
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.704
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.693
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.693
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.691
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.680
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.677
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.676
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.672
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.669
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.664
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.653
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.644
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.644
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.635
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.624
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.619
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.619
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.606
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.602
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.602
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.600
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.580
|
|
|
|
positive regulation of metanephros development
|
GO:0072216 |
9 |
0.577
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.574
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.571
|
Mouse |
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.567
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.556
|
|
|
|
phospholipase c activating angiotensin activated signaling pathway
|
GO:0086097 |
1 |
0.545
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.544
|
Mouse |
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.540
|
|
|
|
regulation of monooxygenase activity
|
GO:0032768 |
7 |
0.540
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.535
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.534
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.531
|
|
|
|
lymph vessel morphogenesis
|
GO:0036303 |
11 |
0.525
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.524
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.519
|
Worm |
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.516
|
|
|
|
regulation of cell aging
|
GO:0090342 |
9 |
0.511
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.509
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.504
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.495
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.484
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.481
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.471
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.470
|
Mouse |
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.468
|
|
|
|
bronchus morphogenesis
|
GO:0060434 |
2 |
0.468
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.465
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.461
|
|
|
|
response to activity
|
GO:0014823 |
13 |
0.458
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.458
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.452
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.445
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.438
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.435
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.435
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.435
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.433
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.433
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.433
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.430
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.429
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.429
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.426
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.420
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.417
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.410
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.410
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.408
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.406
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.404
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.402
|
|
|
|
face development
|
GO:0060324 |
38 |
0.400
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.398
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.397
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.395
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.394
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.392
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.388
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.383
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.382
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.375
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.369
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.367
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.360
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.357
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.357
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.345
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.344
|
|
|
|
regulation of lung blood pressure
|
GO:0014916 |
2 |
0.339
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.338
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.338
|
|
|
|
regulation of anti mullerian hormone signaling pathway
|
GO:1902612 |
1 |
0.337
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.337
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.333
|
|
|
|
superoxide anion generation
|
GO:0042554 |
11 |
0.333
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.332
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.326
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.324
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.322
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.321
|
|
|
|
regulation of membrane protein ectodomain proteolysis
|
GO:0051043 |
3 |
0.320
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.319
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.314
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.308
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.307
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902218 |
1 |
0.305
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.302
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.301
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.301
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.300
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.296
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.295
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.294
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.290
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.289
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.289
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.289
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.288
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.284
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.283
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.280
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.279
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.275
|
|
|
|
positive regulation of nitric oxide synthase activity
|
GO:0051000 |
2 |
0.274
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.274
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.270
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.269
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.267
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.264
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.264
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.263
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.259
|
|
|
|
regulation of tolerance induction to self antigen
|
GO:0002649 |
1 |
0.256
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.255
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.251
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.251
|
|
|
|
positive regulation of dendritic spine development
|
GO:0060999 |
12 |
0.249
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.248
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.248
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.246
|
|
|
|
regulation of response to osmotic stress
|
GO:0047484 |
3 |
0.244
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.243
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.243
|
|
|
|
direct ossification
|
GO:0036072 |
5 |
0.241
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.239
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.239
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.237
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.237
|
|
|
|
negative regulation of insulin secretion
|
GO:0046676 |
14 |
0.236
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.236
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.236
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.235
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.235
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.235
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.232
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.231
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.229
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.222
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.222
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.222
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.220
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.218
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.218
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.215
|
Mouse |
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.214
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.213
|
|
|
|
negative regulation of vasoconstriction
|
GO:0045906 |
2 |
0.210
|
|
|
|
vasodilation by angiotensin involved in regulation of systemic arterial blood pressure
|
GO:0002033 |
2 |
0.210
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.209
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.208
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.207
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.206
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.206
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.205
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.201
|
|
|
|
growth plate cartilage chondrocyte development
|
GO:0003431 |
3 |
0.201
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.200
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.198
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
13 |
0.198
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.197
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.197
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.196
|
|
|
|
indolalkylamine metabolic process
|
GO:0006586 |
4 |
0.195
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.195
|
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.195
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.192
|
|
|
|
negative regulation of cardiac muscle tissue development
|
GO:0055026 |
8 |
0.192
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.192
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.190
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.189
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.186
|
|
|
|
basement membrane organization
|
GO:0071711 |
8 |
0.184
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.184
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.183
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.182
|
|
|
|
cholesterol import
|
GO:0070508 |
2 |
0.182
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.182
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.181
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.178
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.177
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.176
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.176
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.174
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.174
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.174
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.173
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.172
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.172
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.171
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.171
|
|
|
|
negative regulation of heart rate
|
GO:0010459 |
4 |
0.170
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.170
|
|
|
|
fused antrum stage
|
GO:0048165 |
1 |
0.170
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.169
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.168
|
|
|
|
regulation of response to reactive oxygen species
|
GO:1901031 |
9 |
0.166
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.165
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.163
|
Mouse |
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.160
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.160
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.160
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.159
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.159
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.156
|
|
|
|
regulation of neurotrophin trk receptor signaling pathway
|
GO:0051386 |
4 |
0.156
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.154
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.154
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.154
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.154
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.154
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.153
|
|
|
|
positive regulation of tolerance induction to self antigen
|
GO:0002651 |
1 |
0.153
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.152
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.151
|
|
|
|
antimicrobial peptide secretion
|
GO:0002776 |
1 |
0.151
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.151
|
|
|
|
positive regulation of response to oxidative stress
|
GO:1902884 |
6 |
0.151
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.150
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.150
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.150
|
|
|
|
antibacterial humoral response
|
GO:0019731 |
8 |
0.149
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.148
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.147
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.146
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.146
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.145
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.145
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.144
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.141
|
|
|
|
response to fluid shear stress
|
GO:0034405 |
7 |
0.141
|
|
|
|
nitric oxide mediated signal transduction
|
GO:0007263 |
4 |
0.139
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.139
|
|
|
|
neural plate mediolateral regionalization
|
GO:0021998 |
1 |
0.138
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.138
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.138
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.137
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.136
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.136
|
|
|
|
positive regulation of monooxygenase activity
|
GO:0032770 |
2 |
0.135
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.135
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.135
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.133
|
|
|
|
tendon development
|
GO:0035989 |
6 |
0.130
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.130
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.129
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.129
|
|
|
|
cellular response to sterol depletion
|
GO:0071501 |
4 |
0.126
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.126
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.124
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.122
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.121
|
|
|
|
negative regulation of neuron migration
|
GO:2001223 |
6 |
0.121
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.121
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.120
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.120
|
|
|
|
positive regulation of rho protein signal transduction
|
GO:0035025 |
7 |
0.120
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.119
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.118
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.118
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.118
|
|
|
|
collagen catabolic process
|
GO:0030574 |
6 |
0.118
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.118
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.117
|
|
|
|
negative regulation of endodermal cell differentiation
|
GO:1903225 |
1 |
0.116
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902239 |
1 |
0.115
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.115
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.114
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.114
|
|
|
|
response to dexamethasone
|
GO:0071548 |
8 |
0.113
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.113
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.112
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.112
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.112
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.112
|
|
|
|
positive regulation of filopodium assembly
|
GO:0051491 |
10 |
0.111
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.111
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.111
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.110
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.110
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.110
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.109
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.108
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.108
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.107
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.107
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.105
|
|
|
|
lateral mesoderm morphogenesis
|
GO:0048369 |
3 |
0.105
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.105
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
13 |
0.105
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.104
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.104
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.103
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.103
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.103
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.103
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.103
|
|
|
|
detection of chemical stimulus involved in sensory perception of taste
|
GO:0050912 |
3 |
0.102
|
|
|
|
negative regulation of chondrocyte differentiation
|
GO:0032331 |
13 |
0.101
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.100
|
|
|
|
negative regulation of anti mullerian hormone signaling pathway
|
GO:1902613 |
1 |
0.099
|
|
|
|
g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger
|
GO:0007199 |
1 |
0.098
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.098
|
|
|
|
renin secretion into blood stream
|
GO:0002001 |
5 |
0.097
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.096
|
|
|
|
aorta development
|
GO:0035904 |
23 |
0.095
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.095
|
|
|
|
negative regulation of heart growth
|
GO:0061117 |
7 |
0.095
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.095
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.094
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.094
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.094
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.093
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.093
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.091
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.091
|
|
|
|
cellular response to dexamethasone stimulus
|
GO:0071549 |
8 |
0.091
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.091
|
|
|
|
astrocyte cell migration
|
GO:0043615 |
3 |
0.090
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.090
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.089
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.089
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.089
|
|
|
|
cellular response to corticosteroid stimulus
|
GO:0071384 |
13 |
0.087
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.087
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.087
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.087
|
Mouse |
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.087
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.086
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.086
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.085
|
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.085
|
|
|
|
nuclear membrane organization
|
GO:0071763 |
4 |
0.085
|
|
|
|
regulation of macrophage chemotaxis
|
GO:0010758 |
8 |
0.085
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.085
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.085
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.085
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.084
|
|
|
|
catecholamine biosynthetic process
|
GO:0042423 |
11 |
0.083
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.082
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.082
|
|
|
|
mesoderm structural organization
|
GO:0048338 |
1 |
0.081
|
|
|
|
membrane protein proteolysis
|
GO:0033619 |
10 |
0.080
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.080
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.079
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.079
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.078
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.077
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.077
|
|
|
|
regulation of interferon gamma secretion
|
GO:1902713 |
3 |
0.077
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.077
|
Mouse |
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.077
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.076
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.076
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.076
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.076
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.076
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.076
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.075
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.075
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.074
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.073
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.073
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.073
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.072
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.071
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.071
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.071
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.071
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.070
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.070
|
|
|
|
mullerian duct regression
|
GO:0001880 |
1 |
0.070
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.069
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.069
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.069
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.068
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.068
|
|
|
|
myeloid dendritic cell differentiation
|
GO:0043011 |
16 |
0.068
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.068
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.068
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.068
|
Mouse |
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.068
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.067
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.066
|
|